Clinical trial
AMPLATZER™ LAA Occluder Post Approval Study
NCT02964208 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AMPLATZER™ LAA Occluder Post Approval Study
- Lead sponsor
- Abbott Medical Devices
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 8, 2016
- Completion date
- August 10, 2022
- Enrollment
- 520 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.